{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T17:39:50Z","timestamp":1779903590704,"version":"3.53.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[1991,3,1]],"date-time":"1991-03-01T00:00:00Z","timestamp":667785600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Agents and Actions"],"published-print":{"date-parts":[[1991,3]]},"DOI":"10.1007\/bf01980881","type":"journal-article","created":{"date-parts":[[2005,8,3]],"date-time":"2005-08-03T07:40:39Z","timestamp":1123054839000},"page":"245-252","source":"Crossref","is-referenced-by-count":22,"title":["Effects of histamine H1- and H2-receptor antagonists on cardiovascular function during systemic anaphylaxis in guinea pigs"],"prefix":"10.1007","volume":"32","author":[{"given":"S. B.","family":"Felix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Niemczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Ochsenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Shirani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Bl\u00f6mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF01980881_CR1","first-page":"93","volume-title":"Human inflammatory disease, clinical immunology","author":"R. Levi","year":"1988","unstructured":"R. Levi,Cardiac anaphylaxis: Models, mediators, mechanisms, and clinical considerations. InHuman inflammatory disease, clinical immunology, vol. 1. pp. 93\u2013105 (Eds. G. Marone, L. M. Lichtenstein, M. Condorelli and A. S. Fauci) B. C. Decker, Inc., Toronto 1988."},{"key":"BF01980881_CR2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0014-2999(77)90120-0","volume":"44","author":"H. Anhut","year":"1977","unstructured":"H. Anhut, W. Bernauer and B. A. PeskarRadioimmunological determination of thromboxane release in cardiac anaphylaxis. Europ. J. Pharmacol.44, 85\u201388 (1977).","journal-title":"Europ. J. Pharmacol."},{"key":"BF01980881_CR3","first-page":"157","volume":"217","author":"G. Allan","year":"1988","unstructured":"G. Allan and R. Levi,Thromboxane, and prostacyclin release during cardiac immediate hypersensitivity reactions in vitro. J. Pharmacol. Exp. Ther.217, 157\u2013161 (1988).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF01980881_CR4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1476-5381.1983.tb11051.x","volume":"80","author":"U. Aehringhaus","year":"1983","unstructured":"U. Aehringhaus, B. A. Peskar, H. R. Wittenberg and R. H. W\u00f6lbling,Effect of inhibition of synthesis and receptor antagonism of SRS-A in cardiac anaphylaxis. Br. J. Pharmacol.80, 73\u201380 (1983).","journal-title":"Br. J. Pharmacol."},{"key":"BF01980881_CR5","first-page":"47","volume-title":"Advances in prostaglandin, thromboxane and leukotriene research","author":"P. Weinerowski","year":"1985","unstructured":"P. Weinerowski, G. Wittmann, U. Aehringhaus and B. A. Peskar,Pharmacological modification of leukotriene release and coronary constrictor effect in cardiac anaphylaxis. InAdvances in prostaglandin, thromboxane and leukotriene research, vol. 13. pp. 47\u201350 (Ed. G. G. Neri Serneri) Raven Press, New York 1985."},{"key":"BF01980881_CR6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/01.RES.54.2.117","volume":"54","author":"R. Levi","year":"1984","unstructured":"R. Levi, J. A. Burke, Z.-G. Guo, Y. Hattori, C. M. Hoppens, L. M. McManus, D. J. Hanahan and R. N. Pinckard,Acetyl glyceryl ether phosphorylcholine (AGEPC) a putative mediator of cardiac anaphylaxis in the guinea pig. Circ. Res.54, 117\u2013124 (1984).","journal-title":"Circ. Res."},{"key":"BF01980881_CR7","first-page":"180","volume":"188","author":"J. H. McNeil","year":"1974","unstructured":"J. H. McNeil and S. C. Verma,Blockade by burimamide of the effects of histamine and histamine analogs on cardiac contractility, phosphorylase activation and cyclic adenosine monophosphate. J. Pharmacol. Exp. Ther.188, 180\u2013188 (1974).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF01980881_CR8","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0014-2999(75)90117-X","volume":"30","author":"R. Levi","year":"1975","unstructured":"R. Levi, N. Capurro, C.-H. Lee,Pharmacological characterization of cardiac histamine receptors: sensitivity to H 1- and H2-receptor agonists and antagonists. Eur. J. Pharmacol.30, 328\u2013335 (1975).","journal-title":"Eur. J. Pharmacol."},{"key":"BF01980881_CR9","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1016\/0024-3205(80)90209-X","volume":"26","author":"R. Ginsburg","year":"1980","unstructured":"R. Ginsburg, M. R. Bristow, E. B. Stinson and D. C. Harrison,Histamine receptors in the human heart. Life Sci.26, 2245\u20132249 (1980).","journal-title":"Life Sci."},{"key":"BF01980881_CR10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF01852128","volume":"179","author":"G. Baumann","year":"1981","unstructured":"G. Baumann, S. B. Felix, J. Schrader, C. D. Heidecke, G. Riess, W. D. Erhardt, L. Ludwig, U. Loher, F. Sebening and H. Bl\u00f6mer,Cardiac contractile and metabolic effects mediated via the myocardial H 2-receptor adenylate cyclase system. Res. Exp. Med.179, 81\u201398 (1981).","journal-title":"Res. Exp. Med."},{"key":"BF01980881_CR11","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1378\/chest.75.5.597","volume":"75","author":"G. R. Hageman","year":"1979","unstructured":"G. R. Hageman, F. Urthaler, J. H. Isobe and T. N. James,Chronotropic and dromotropic effects of histamine on the canine heart. Chest75, 597\u2013604 (1979).","journal-title":"Chest"},{"key":"BF01980881_CR12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF01852292","volume":"180","author":"G. Baumann","year":"1982","unstructured":"G. Baumann, U. Loher, S. B. Felix, C. D. Heidecke, G. Riess, L. Ludwig and H. Bl\u00f6mer,Deleterious effects of cimetidine in the presence of histamine on coronary circulation. Possible clinical implications in anaphylactic states in individuals with coronary heart disease. Res. Exp. Med.180, 209\u2013213 (1982).","journal-title":"Res. Exp. Med."},{"key":"BF01980881_CR13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000138155","volume":"32","author":"J. T. Saari","year":"1986","unstructured":"J. T. Saari,Characterization of the vascular response to histamine in rabbit hearts using cimetidine. Pharmacology32, 80\u201389 (1986).","journal-title":"Pharmacology"},{"key":"BF01980881_CR14","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/01.RES.61.2.280","volume":"61","author":"N. Toda","year":"1987","unstructured":"N. Toda,Mechanism of histamine actions in human coronary arteries. Circ. Res.61, 280\u2013286 (1987).","journal-title":"Circ. Res."},{"key":"BF01980881_CR15","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/BF01906682","volume":"83","author":"S. B. Felix","year":"1988","unstructured":"S. B. Felix, G. Baumann, S. Helmus and U. Sattelberger,The role of histamine in cardiac anaphylaxis; characterization of histaminergic H1- and H2-receptor effects. Basic Res. Cardiol.83, 531\u2013539 (1988).","journal-title":"Basic Res. Cardiol."},{"key":"BF01980881_CR16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF01851842","volume":"177","author":"G. Neumann","year":"1980","unstructured":"G. Neumann, W. Erhardt, B. Oberhuber, R. Fritsch and G. Bl\u00fcmel,A new highly potent and short-acting analgesic, Carfentanyl (R33799) in combination with the hypnotic agent Etomidat (R26490), as a method of analgesia in guinea pigs. Res. Exp. Med.177, 135\u2013143 (1980).","journal-title":"Res. Exp. Med."},{"key":"BF01980881_CR17","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/00005344-199006000-00018","volume":"15","author":"S. B. Felix","year":"1990","unstructured":"S. B. Felix, G. Baumann, T. Hashemi, M. Niemczyk, Z. Ahmad and W. E. Berdel,Characterization of cardiovascular events mediated by platelet activating factor during systemic anaphylaxis. J. Cardiovasc. Pharmacol.15, 989\u2013997 (1990).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"BF01980881_CR18","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/01.RES.36.4.520","volume":"36","author":"N. Capurro","year":"1975","unstructured":"N. Capurro and R. Levi,The heart as a target organ in systemic allergic reactions. Comparison of cardiac anaphylaxis in vivo and in vitro. Circ. Res.36, 520\u2013528 (1975).","journal-title":"Circ. Res."},{"key":"BF01980881_CR19","first-page":"1269","volume":"15","author":"E. T. Nishimura","year":"1966","unstructured":"E. T. Nishimura, R. Patterson, J. N. Fink and J. N. Wennemark,Myocardial lesions associated with experimental passive transfer of immediate type hypersensitivity. Lab. Invest.15, 1269\u20131278 (1966).","journal-title":"Lab. Invest."},{"key":"BF01980881_CR20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0021-8707(96)90013-1","volume":"37","author":"R. Patterson","year":"1966","unstructured":"R. Patterson, J. N. Fink, J. Wennemark, J. Baum, J. Pruzansky and E. T. Nishimura,The biologic consequences of the immediate type hypersensitivity transferred from man to monkey. J. Allergy37, 295\u2013310 (1966).","journal-title":"J. Allergy"},{"key":"BF01980881_CR21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00000029","volume":"190","author":"S. B. Felix","year":"1990","unstructured":"S. B. Felix, G. Baumann and W. E. Berdel,Systemic anaphylaxis\u2014separation of cardiac reactions from respiratory and peripheral vascular events. Res. Exp. Med.190, 239\u2013252 (1990).","journal-title":"Res. Exp. Med."},{"key":"BF01980881_CR22","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/BF01716952","volume":"60","author":"K. Pavek","year":"1982","unstructured":"K. Pavek, A. Wegmann, L. Nordstr\u00f6m and D. Schwander,Cardiovascular and respiratory mechanisms in anaphylactic and anaphylactoid shock reactions. Klin. Wochenschr.60, 941\u2013947 (1982).","journal-title":"Klin. Wochenschr."},{"key":"BF01980881_CR23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0002-9343(84)90717-4","volume":"77","author":"H. J. Silvermann","year":"1984","unstructured":"H. J. Silvermann, C. Van Hook and E. F. Haponik,Hemodynamic changes in human anaphylaxis. Am. J. Med.77, 341\u2013344 (1984).","journal-title":"Am. J. Med."},{"key":"BF01980881_CR24","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1084\/jem.170.6.1905","volume":"170","author":"A. Guhlmann","year":"1989","unstructured":"A. Guhlmann, A. Keppler, S. K\u00e4stner, H. Krieter, U. B. Br\u00fcckner, K. Messmer and D. Keppler,Prevention of endogenous leukotriene production during anaphylaxis in the guinea pig by an inhibitor of leukotriene biosynthesis (MK-886) but not by dexamethasone. J. Exp. Med.170, 1905\u20131918 (1989).","journal-title":"J. Exp. Med."},{"key":"BF01980881_CR25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000234083","volume":"80","author":"H. Darius","year":"1986","unstructured":"H. Darius, J. B. Smith and A. M. Lefer,Inhibition of the platelet activating factor mediated component of guinea pig anaphylaxis by receptor antagonists. Int. Archs. Allergy Appl. Immun.80, 369\u2013375 (1986).","journal-title":"Int. Archs. Allergy Appl. Immun."},{"key":"BF01980881_CR26","first-page":"38","volume":"6","author":"W. Lorenz","year":"1985","unstructured":"W. Lorenz and A. Doenicke,H 1 and H2 blockade: A prophylactic principle in anesthesia and surgery against histaminerelease responses of any degree of severity: Part I. N. Engl. Res. Allerg. Proc.6, 38\u201357 (1985).","journal-title":"N. Engl. Res. Allerg. Proc."},{"key":"BF01980881_CR27","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2500\/108854185779045206","volume":"6","author":"W. Lorenz","year":"1985","unstructured":"W. Lorenz and A. Doenicke,H 1 and H2 blockade: A prophylactic principle in anesthesia and surgery against histaminerelease responses of any degree of severity: Part II. N. Engl. Res. Allerg. Proc.6, 174\u2013192 (1985).","journal-title":"N. Engl. Res. Allerg. Proc."}],"container-title":["Agents and Actions"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01980881.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01980881\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01980881","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T21:10:24Z","timestamp":1557781824000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01980881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,3]]},"references-count":27,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[1991,3]]}},"alternative-id":["BF01980881"],"URL":"https:\/\/doi.org\/10.1007\/bf01980881","relation":{},"ISSN":["0065-4299","1420-908X"],"issn-type":[{"value":"0065-4299","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,3]]}}}